Company / Cash & Equivalents
Genasys Inc. Cash & Equivalents History
FY2011-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$11.1M
FY2018
5-year range
$11.1M / $23.9M
FY2014-FY2018
Trend
-17.8%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $24M in FY2015 to $11M in FY2018.
Based on SEC 10-K filings.
$11M in FY2018 with a 5-year CAGR of -4.4%.
Declined from $18M to $11M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -22.6%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Genasys Inc.'s cash & equivalents has declined for 3 consecutive years.
- 5-year CAGR of -4.4%, indicating a declining trend.
- In FY2018, cash & equivalents decreased 17.8% year-over-year.
- Peak cash & equivalents was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score 3.00 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $11.1M | -17.8% |
| FY2017 | $13.5M | -26.5% |
| FY2016 | $18.3M | -23.3% |
| FY2015 | $23.9M | +51.2% |
| FY2014 | $15.8M | +14.0% |
| FY2013 | $13.9M | -0.1% |
| FY2012 | $13.9M | +155.9% |
| FY2011 | $5.4M | - |
As of FY2018 · SEC 10-K · Updated Jun 24, 2026